Discovery could facilitate early treatment, obviate need to give antibiotics to all newborns with suspected sepsis but no diagnosis.

Monday, October 28, 2024 Gene Signature at Birth Predicts Sepsis in Newborns Before Signs Appear Illustration of a DNA double helix resting on a printout of the genetic code letters A, T, C and G. Credit: NHGRI A four-gene signature detectable in newborns' blood at birth predicts before symptom onset whether a baby will develop sepsis during the first week of life, NIAID-funded researchers report. Sepsis is a potentially life-threatening condition that arises when the body's response to infection injures its own tissues and organs. Using the newly discovered genetic signature to identify newborns who will develop sepsis could facilitate early treatment and obviate the need to give antibiotics to all newborns with suspected sepsis but lacking a definitive diagnosis. The findings are published in the journal eBioMedicine. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period.  This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107